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In eukaryotic ribosome biogenesis, U3 snoRNA base-pairs with the pre-rRNA to 
promote its processing. However, U3 must be removed to allow folding of the central 
pseudoknot, a key feature of the small subunit. Previously, my work contributed to showing 
that the DEAH/RHA RNA helicase Dhr1 dislodges U3 from the pre-rRNA. DHR1 can be 
linked to UTP14, encoding an essential protein of the pre-ribosome, through genetic 
interactions with the rRNA methyltransferase Bud23. Here, I report that Utp14 regulates 
Dhr1. Mutations within a discrete region of Utp14 reduced its interaction with Dhr1 that 
correlated with reduced function of Utp14. These mutants accumulated Dhr1 and U3 in a 
pre-40S particle, mimicking a helicase inactive Dhr1 mutant. This similarity in the 
phenotypes led us to propose that Utp14 activates Dhr1. Indeed, Utp14 formed a complex 
with Dhr1 and stimulated its unwinding activity in vitro. Moreover, the utp14 mutants that 
mimicked a catalytically inactive dhr1 mutant in vivo showed reduced stimulation of 
unwinding activity in vitro. Dhr1 binding to the pre-ribosome was substantially reduced 
 vi 
only when both Utp14 and Bud23 are depleted. Thus, Utp14 is bifunctional; together with 
Bud23 it is needed for stable interaction of Dhr1 with the pre-ribosome and Utp14 activates 
Dhr1 to dislodge U3. 
 vii 
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Chapter 1 Introduction1 
1.1 Overview 
Ribosomes are fundamentally important and conserved molecular machines that 
translate genetic information into protein for the cells. A ribosome is a ribonucleoprotein 
complex that is composed of RNAs and proteins. It consists of two subunits: a small 
subunit (SSU) and a large subunit (LSU). In eukaryotes, the SSU sediments at 40S and 
contains 18S rRNA and 33 ribosomal proteins and the LSU sediments at 60S and has 5S 
rRNA, 5.8S rRNA, 25S rRNA and 46 ribosomal proteins (1). Each subunit has its specific 
function. The SSU contains the decoding center which is important for monitoring the 
complementarity of tRNA and mRNA, whereas the LSU has the peptidyl-transferase center 
which is responsible for peptide-bond formation during translation (2). The ribosomal 
subunits are pre-assembled in the nucleus, and undergo final maturation in the cytoplasm. 
These processes are very complicated and require all three RNA polymerases, more than 
200 trans-acting factors, and highly ordered rRNA processing steps (2). Although the 
maturation and export of the SSU have been studied for several decades, they are still not 
well understood. My thesis has focused on understanding an aspect of the maturation of 
the SSU in the budding yeast, Saccharomyces cerevisiae. 
                                                 
1Chapter 1 is mainly based on previously published article: Zhu J, Liu X, Anjos M, Correll CC, Johnson 
AW. Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome. 
Mol Cell Biol. 2016;36(6):965-78. PMCID: 4810474. I contributed to the whole chapter 1. 
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1.2 Ribosome Biogenesis 
Ribosome biogenesis is a complicated and tightly regulated process. The starting 
point of ribosome biogenesis is in the nucleolus, a specialized compartment of the nucleus. 
In eukaryotes, three of the rRNAs (18S, 5.8S, and 25S/28S rRNAs) are produced from a 
long primary rRNA (35S) precursor transcript from the tandemly repeated ribosomal rRNA 
genes (about 150 copies in yeast Saccharomyces cerevisiae). 35S rRNA is synthesized by 
RNA polymerase I, while the precursor of 5S rRNA is transcribed by RNA polymerase III, 
and the genes of ribosomal proteins are transcribed by RNA polymerase II (3).  
In yeast, the primary rRNA precursor contains a 5’ external transcribed spacer 
(ETS), following by 18S rRNA sequence, internal transcribed spacer 1 (ITS1), 5.8S rRNA 
sequence, ITS2, 25S rRNA sequence, and 3’ETS. During the early transcription of the 
rRNA precursor, a subset of biogenesis trans-acting factors, ribosomal proteins and small 
nucleolar ribonucleoproteins (snoRNPs) associate with the nascent pre-rRNAs, to form 
RNPs which can be visualized as “terminal knobs” in Miller spreads (3, 4). These terminal 
knobs are small subunit (SSU) processomes, or 90S pre-ribosome particles, which are then 
split into pre-40S and pre-60S pre-ribosomal particles (5, 6).   
In the process of rRNA maturation, the ETS and ITS sequences of 35S pre-rRNA 
have to be removed. This process is accomplished by endonucleolytic and exonucleolytic 
cleavage steps (Illustration 1.1). The separation of pre-40S from pre-60S subunit can be 
done by cleaving A0, A1 and A2 sites. After A0, A1 and A2 cleavage, 20S and 27SA2 pre-
rRNA are generated. The 20S pre-rRNA, a precursor of mature 18S, is exported to 
cytoplasm and undergoes final cleavage at the D site by Nob1 (7). The 27SA2 pre-rRNA, 
a precursor for 5.8S and 25S rRNA, can be processed by two alternative pathways: 
cleavage at A3 followed by cleavage at B1S yields 27SB pre-rRNA; or cleavage at site 
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B1L, yielding 27SBL precursor. Both 27SB and 27SBL precursors undergo subsequent 
processing to yield mature 25S and 5.8S rRNA. 
 
 





1.3 The SSU processome 
The SSU processome is a 2.2 MDa ribonucleoprotein complex and contains the 
nascent transcript of pre-rRNA, ribosome biogenesis factors, ribosomal proteins and 
snoRNPs (9).There are six sub-complexes that have been described: (i) Utp-A (U three 
associate protein-A) sub-complex (t-Utp4, 5, 8, 9, 10, 15, 17 and Pol5), which is required 
both for the transcription of the pre-rRNA and its processing, (ii) Utp-B subcomplex (Utp1, 
6, 12, 13, 18 and 21) and (iii) Utp-C (Utp22, Rrp7 and the four subunits of casein kinase 
II: Cka1, Cka2, Ckb1 and Ckb2), which are only known to play a role in pre-rRNA 
processing (5, 9, 10), (iv) U3 snoRNP “monoparticle”, (v) Mpp10 sub-complex and (vi) 
the Bms1/Rcl1 sub-complex. These subcomplexs join to the pre-rRNA in highly ordered 
fashion to ensure the accurate maturation of rRNA and ribosome assembly (11). 
 
1.3.1 U3 snoRNA 
U3 snoRNA is an evolutionarily conserved snoRNA and is instrumental in 
orchestrating early pre-rRNA processing (12). It belongs to the C/D box family snoRNA 
(Illustration 1.2) and was discovered in 1968 by James L. Hodnett and Harris Busch (13). 
U3 snoRNA is required for A0, A1 and A2 cleavage and can be characterized into three 
key domains based on its secondary structure: a 5’ domain, a ‘hinge’ region and a 3’ 
terminal hairpin domain (12, 14-17). The 5’ domain has the conserved sequence boxes 






Illustration 1.2 Secondary structure of U3 snoRNA from Saccharomyces cerevisiae. 
(Adapted from (17) )  
U3 hybridizes with the pre-rRNA at multiple sites within the 35S precursor: at sites 
in the 5’ external transcribed spacer; the 5’-end of 18S; and additional positions within 18S 
(12, 15, 16, 18-20). The central pseudoknot (CPK) is a key architectural feature of the small 
subunit (SSU) that physically coordinates the four rRNA domains and sets up the decoding 
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center. The CPK is formed when nucleotides (nts) in the loop of the first stem-loop 
structure of 18S (nts 4 to 20) base pair with nts 1137 to 1144 of 18S. In the pre-ribosome, 
U3 is expected to base-pair with these elements of the CPK based on genetic and 
phylogenetic covariation analysis (15, 16, 18, 20). However, pre-rRNA hybridization with 
U3 blocks the folding of the CPK. Thus, removal of U3 from the pre-ribosome is a 
prerequisite for, and perhaps promotes, CPK formation. We have recently shown that Dhr1, 
a ribosomal biogenesis factor, is responsible for removing U3 from the pre-rRNA to allow 
folding of the CPK (21). 
 
1.3.2 Dhr1 
There are nineteen RNA helicases that are involved in ribosome biogenesis in yeast, 
17 of which are essential (21). Based on conserved sequence motifs, these helicases are 
characterized as either DEAD or DEAH/RHA enzymes. Dhr1 is an essential DEAH/RHA 
ATP-dependent RNA helicases. It is required for pre-rRNA A2 cleavage and unwinds U3 
snoRNA from the pre-40S particle (21, 22). How Dhr1 activity is regulated to ensure its 
activity at the correct point in folding and assembly of the SSU is unknown. 
Most DExD/H RNA helicases lack intrinsic regulation (23). Rather, they contain 
ancillary domains flanking the helicase core that provide binding sites for regulatory 
cofactors (23). DEAH/RHA helicases commonly use G-Patch proteins as accessory factors 
for activation of enzymatic activity (24). For example the yeast spliceosomal helicase Prp2 
requires the G-Patch protein Spp2 and Prp43, involved in ribosome biogenesis and 
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spliceosome disassembly, is stimulated by at least three different G-patch proteins (Ntr1, 
Pfa1 and Gno1) that recruit Prp43 to its respective substrates (reviewed in 24). 
To identify regulators of Dhr1 we explored candidate proteins that interact with it. 
The methyltransferase Bud23 modifies the guanosine base at position 1575 in 18S rRNA 
(25, 26). Bud23 is recruited to the pre-ribosome at a relatively late step in 40S biogenesis, 
before A2 cleavage, and remains associated with the pre-40S particle in the nucleus (25, 
27). We took advantage of the slow growth defect of bud23 mutants as a genetic entry point 
to dissect a constellation of functionally linked proteins. We found that mutations in DHR1, 
UTP2 or UTP14 partially suppressed the growth defect and 40S assembly defect of bud23∆ 
mutants (21, 25, 27). We also showed that Bud23 binds to the N-terminal extension of 
Dhr1, making Bud23 a candidate for recruiting or regulating Dhr1 (28). However, 
disruption of the interaction between Bud23 and Dhr1 had no observed effect on cell 
growth, leaving open the question of how Dhr1 is regulated.  
1.3.3 Utp14 
Utp14 was discovered as one of the Utp proteins of the SSU processome in yeast 
(9). It is required for the formation of SSU processome and maturation of the 18S rRNA 
(9). Although human Utp14c is reported as a retrogene, and mouse Utp14b is significant 
in a mouse model of male infertility, the molecular function of Utp14 has remained elusive 
(29). Recently, we identified a Utp14-A758G mutant that suppressed the growth defect 
found in bud23Δ yeast (27). We also found that Utp14 WT co-purified with Bud23, and 
the absence of BUD23 caused mislocalization of Utp14 WT (27). Utp14 was found in 90S 
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particle containing the SSU processome, Mpp10, Imp4 and the U3 snoRNA, and was found 
in the pre-40S particle containing 20S pre-rRNA (27). In a bud23Δ mutant, Utp14 lost the 
association with the 20S pre-rRNA but not with U3, while the utp14-A758G mutation could 
partially restore the association with the 20S pre-rRNA (27). Although Utp14 has been 
suggested to be an ATPase, it is unlikely to be able to hydrolyze ATP because its putative 
Walker-A motif is not conserved when comparing the sequences of other homologs (27, 
30). Therefore, the exact role of Utp14 in ribosome biogenesis remained to be identified. 
In this thesis, I show that Utp14 interacts directly with Dhr1 and activates its unwinding 
activity. My data suggest that Utp14 activates Dhr1 and together with Bud23 recruits this 






















Chapter 2 Materials and Methods for Chapter 32 
2.1 Strains, plasmids, and media. 
Table 2.1 list all yeast strains used in Chapter 3. All yeast strains used in this study 
were grown at 30°C in YEPD (2% peptone, 1% yeast extract, 2% dextrose) or YEPgal (2% 
peptone, 1% yeast extract, 1% galactose) or synthetic dropout (SD) medium containing 2% 
glucose, unless otherwise indicated. To make AJY3243, KanMX-Gal1-3XHA was 
amplified from pAJ438 with AJO1948 and AJO1949. The PCR product was integrated into 
BY4743. After sporulation and dissection, the desired integrant was selected. AJY3245 
was made by integrating bud23Δ:: Natr PCR product into AJY3243. Tables2.2 and 2.3 list 
all plasmids and oligonucleotides used in chapter 3, respectively. 
Table 2.1 Yeast strains used in Chapter 3 
                                                 
2 Chapter 2 is mainly based on previously published article: Zhu J, Liu X, Anjos M, Correll CC, Johnson 
AW. Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome. 
Mol Cell Biol. 2016;36(6):965-78. PMCID: 4810474. I contributed to 2.1, 2.2, 2.4, 2.5, 2.6, 2.7. 
 
Strain Genotype Source 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems 
PJ69-4α MATα trp1-901 leu2-3,112 ura3-52 his3Δ200 
gal4Δ gal80ΔLYS2::GAL1-HIS3 GAL2-ADE met2::GAL7-LACZ 
(31) 
AJY2161 MATa bud23Δ::KanMX6 his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 (26) 
AJY3711 MATa KanMX6-PGAL1-3xHA-Dhr1 his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0 
(21) 
AJY3243 MATaKanMX6-PGAL1-3xHA-UTP14 his3∆1 leu2∆0 ura3∆0  This study 
AJY3245 MATaKanMX6-PGAL1-3xHA-UTP14 bud23∆::Natr his3∆1 
leu2∆0 ura3∆0 
This study 
AJY3243 MATaKanMX6-PGAL1-3xHA-UTP14 his3∆1 leu2∆0 ura3∆0 This study 
L40 MATahis3∆200 trp1-901, 112 ade2 LYS2::(LexAop)4-His3 




Plasmid Description Source or reference 
pACT2 Gal4AD-HA LEU2 2μ Clontech 
pAJ438 pFA6a-kanMX6-PGAL1-3HA (33) 
pAJ1918 utp14-A758G URA3 CEN ARS (27) 
pAJ1919 UTP14 URA3 CEN ARS (27) 
pAJ2311 DHR1-13myc LEU2 CEN ARS (34) 
pAJ2312 pET21a-DHR1-6xHis (21) 
pAJ2321 Gal4AD-HA-UTP14LEU2 2μ This study 
pAJ2330 Gal4BD-c-myc-dhr1 aa1-838 TRP1 2μ This study 
pAJ2331 Gal4BD-c-myc-dhr1 aa319-838 TRP1 2μ This study 
pAJ2332 Gal4BD-c-myc-dhr1 aa319-1267 TRP1 2μ This study 
pAJ2334 Gal4AD-HA-utp14 aa1-706 LEU2 2μ This study 
pAJ2335 Gal4AD-HA-utp14 aa707-899LEU2 2μ This study 
pAJ2341 Gal4AD-HA-utp14 aa1-813LEU2 2μ This study 
pAJ2342 Gal4AD-HA-utp14 aa1-654LEU2 2μ This study 
pAJ2343 Gal4AD-HA-utp14 aa1-564LEU2 2μ This study 
pAJ2344 Gal4AD-HA-utp14 aa1-265LEU2 2μ This study 
pAJ2345 Gal4AD-HA-utp14 aa266-899 LEU2 2μ This study 
pAJ2346 Gal4AD-HA-utp14 aa565-899LEU2 2μ This study 
pAJ2347 Gal4AD-HA-utp14 aa655-899 LEU2 2μ This study 
pAJ2394 LexABD-c-myc-DHR1 TRP1 2μ This study 
pAJ2593 DHR1URA3 CEN ARS (34) 
pAJ2795 Gal4AD-HA-dhr1 aa467-1267 LEU2 2μ (34) 
pAJ2796 Gal4AD-HA-dhr1aa1-142 LEU2 2μ (34) 
 




Plasmid Description Source or reference 
pAJ2797 Gal4AD-HA-dhr1aa1-467 LEU2 2μ (34) 
pAJ2922 Gal4BD-c-myc-DHR1 (34) 
pAJ3081 dhr1-K420A-13myc LEU2 CEN ARS (21) 
pAJ3132 utp14-I755T URA3 CEN ARS This study 
pAJ3136 utp14-E757G URA3 CEN ARS This study 
pAJ3145 utp14-V754G URA3 CEN ARS This study 
pAJ3145 utp14-A760P URA3 CEN ARS This study 
pAJ3263 Gal4AD-HA-utp14 D753A V754A I755A E757A F759A 
LEU2 2μ 
This study 
pAJ3264 utp14-V754G I755T E757G A758G A760P URA3 CEN 
ARS 
This study 
pAJ3265 Gal4AD-HA-utp14 ∆aa719-780  LEU2 2μ This study 
pAJ3266 Gal4AD-HA-utp14 V754G I755T E757G A758G A760P 
LEU2 2μ 
This study 
pAJ3267 utp14-∆aa719-780 URA3 CEN ARS This study 
pAJ3276 utp14-D753A V754A I755A E757A F759A URA3 CEN 
ARS 
This study 
pAJ3307 pET16a-6xHis-UTP14 This study 
pAJ3308 UTP14-GFP  URA3 CEN ARS This study 
pAJ3309 utp14 V754G I755T E757G A758G A760P -GFP URA3 
CEN ARS 
This study 
pAJ3310 utp14 D753A V754A I755A E757A F759A -GFP URA3 
CEN ARS 
This study 
pAJ3313 utp14 ∆aa719-780 -GFP URA3 CEN ARS This study 
pAJ3314 pET16a-6xHis-utp14  ∆aa719-780  This study 
pAJ3315 pET16a-6xHis-utp14 D753A V754A I755A E757A 
F759A 
This study 
pAJ3331 6xHis-UTP14  URA3 CEN ARS This study 
pAJ3421 utp14 aa1-813 URA3 CEN ARS This study 
 









Plasmid Description Source or reference 
pAJ3422 utp14 aa1-706 URA3 CEN ARS This study 
pAJ3423 utp14 aa1-654 URA3 CEN ARS This study 
pAJ3424 utp14 aa1-564 URA3 CEN ARS This study 
pAJ3425 utp14 aa1-265   URA3 CEN ARS This study 
pAJ3426 utp14 aa266-899 URA3 CEN ARS This study 
pAJ3427 utp14 aa565-899 URA3 CEN ARS This study 
pAJ3428 utp14 aa655-899 URA3 CEN ARS This study 
pAJ3429 utp14 aa707-899 URA3 CEN ARS This study 
pAJ3455 dhr1 aa319-1267 URA3 CEN ARS This study 
pAJ3456 dhr1 aa467-1267 URA3 CEN ARS This study 
pAJ3457 dhr1 aa1-838 URA3 CEN ARS This study 
pAJ3458 dhr1 aa1-142 URA3 CEN ARS This study 
pAJ3459 dhr1 aa1-467 URA3 CEN ARS This study 
pAJ3460 Gal4BD-c-myc-dhr1 aa584-1267 TRP1 2μ This study 
pAJ3461 Gal4BD-c-myc-dhr1 aa839-1267 TRP1 2μ This study 
pAJ3470 dhr1 aa319-838 URA3 CEN ARS This study 
pGBKT7 Gal4BD-c-myc TRP1 2μ Clontech 




Oligonucleotide Target(s) Sequence 
AJO603 35S, 27SA2, 
23S, 21S 
TGTTACCTCTGGGCCCCGATTG 
AJO130 20S TCTTGCCCAGTAAAAGCTCTCATGC 
AJO962 U2 GCGACCAAAGTAAAAGTCAAGAACGACTCCACAAG
TGCGAGGGTCGCGAC 
AJO2194 U3 CTCATCAACCAAGTTGGATTCAGTGGCTC 
AJO944 Utp14 CATAAACTGGACAGTGTTTTCTTCAGACTTTTTATG 





Table 2.3 Oligonucleotides used in Chapter 3 
2.2 Yeast two-hybrid assays 
To test the interaction of Dhr1 and Utp14 by yeast two-hybrid assay, WT and 
mutant DHR1 and UTP14 genes were amplified by PCR using specific pairs of 
oligonucleotides that are listed in Table 3. The PCR products were cut with restriction 
enzymes and were ligated to either pACT2, pGBKT7 orpAJ2394 two-hybrid vectors which 
were also cut with corresponding restriction enzymes. Plasmids were confirmed by 
sequencing. WT or mutant Utp14 was cotransformed with WT Dhr1 into PJ69-4α (31) or 
L40 (32). WT or mutant Dhr1 was cotransformed with WT Utp14 into PJ69-4α (31) or L40 
(32). Transformants were selected on SD Leu− Trp− medium and then patched on SD Leu− 
Trp− His− with or without 3-Amino-1,2,4-triazole (3-AT) to test for activation of UASGAL-
HIS3 or (LexAop)4-HIS3 reporter genes. These plates were incubated at 30°C for 48-72 h. 
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2.3 Screen to identify additional mutants of UTP14 as suppressors of 
thebud23Δmutant. 
To indentify additional mutants of UTP14 that suppressed a bud23Δmutant, UTP14 
was amplified by PCR using oligonucleotides AJO944 and AJO1399 with Taq DNA 
polymerase. The PCR product was cotransformed with HpaI and AatII-digested pAJ1919 
into the bud23Δ mutant strain (AJY2161). The transformants were selected on SD Ura− 
medium at 30°C for 48-72 h. Plasmids were isolated from fast-growing clones and 
sequenced (28). 
2.4 Northern blot analysis 
2.4.1 RNA preparation 
To prepare total RNA, all yeast cultures were grown at 30°C to a density of ~1x107 
cells/ml and RNA was prepared using the hot acidic phenol method (35). For RNA 
isolation from sucrose gradient fractions, 1/10 volume of 20% SDS, 1/10 volume of 3M 
Na Acetate (pH5.5) and 2.375 volumes 100% ethanol were added to each fraction and 
stored at -20°C for 24h. The RNA was collected by centrifugation at 14,000 rpm at 4°C for 
30 min. The RNA pellet was washed once with 70% ethanol, and resuspended in DEPC-
treated ddH2O.  
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2.4.2 Gel and blotting 
For gel analysis of RNAs, a defined quantity of RNA samples were dried by 
vacuum for 20 min in a SpeedVac. The RNA pellet was resuspended by RNA sample buffer 
(50% deionized formamide, 16% 37% formaldehyde, 1X MOPS) and heated at 68°C for 
15 min. RNA dye was added to the samples on ice. Samples were separated on a 1.2% 
agarose formaldehyde gel at 50V for 3 h at room temperature. The gel was rinsed with 
DEPC ddH2O 3 times, shaking for 10 min each, incubated in 1X SSC for 20 min and 
transferred to Zeta probe nitrocellulose membrane by downward capillary transfer using 
the Schleicher & Schuell Truboblotter transfer system. After overnight transfer, the 
membrane was soaked in 20X SSC for 5 min, and crosslinked twice using a Stratagene UV 
Stratalinker 1800 at auto-crosslink setting. 
2.4.3 Hybridization 
 Membranes with RNA were pre-incubated with hybridization solution (5X SSC, 
20mM Na2HPO4 pH7.2, 7% SDS, 1X Denhardt’s, 100μg/ml Denatured herring sperm 
DNA) for 30min at 50°C in the hybridization oven with rotation. The hybridization solution 
was removed and replaced with the same buffer. Radiolabled probes that listed in Table 3 
were added and hybridization was carried out at 50°C for 24 h. The membrane was washed 
twice with wash solution 1 (3X SSC, 10X Denhardt’s, 5% SDS, 25mM NaH2PO4 pH 7.5) 
and washed once with wash solution 2 (1X SSC, 1% SDS). The blotted membrane was 
then exposed to a phosphor screen for 2 h, the screen was scanned with a Typhoon 
FLA9500 and the image was analyzed by Image J. 
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2.5 Sucrose density gradient sedimentation. 
Fresh overnight cultures were innoculated into 250ml SD or YPD media to give 0.1 
OD600 and were grown at 30°C to a density at of ~1x107 cells/ml. Cycloheximide was 
added to a final concentration of 100 μg/ml and the cultures were incubated at 30°C shaker 
for 10 min. The cells were then immediately poured onto centrifuge bottles over ice and 
collected by centrifugation at 5,000 rpm for 5 min in a Beckman JLA-10.5 rotor. Cells 
were then stored at -80°C. To make the cell lysate, cells were thawed on ice and washed 
with lysis buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl2, 7 mM β-
mercaptoethanol, 100 μg/ml cyclohexamide, 1X pepstatin-A, 1X leupeptin, and 1 mM 
PMSF). Cells were resuspended in an equal volume of lysis buffer, glass beads were added 
to 2/3 volume of the cell suspension and cell membranes were lysed by vortexing 30 sec 
for seven times using VWR vortex-genie 2 set to maximum speed with 1min 30sec interval 
on ice. Extracts were then clarified by centrifugation at 14,000 rpm for ten minutes at 4°C. 
The supernatant was collected and transferred to a pre-chilled new tube. The OD260 of the 
cell extract was measured and 9 A260 units was loaded onto a sucrose gradient (7%-47%) 
and centrifuged at 40,000 rpm for 2.5 h using Beckman SW40 rotor. The gradients were 
fractionated using an ISCO model 640 density gradient fractionator while monitoring 
absorbance at 254 nm. To precipitate proteins from fractions, trichloroacetic acid (TCA) 
was added to 1/10 volume of the fraction. These samples were stored at −20°C for 24 h. 
Precipitated proteins were collected by centrifugation at 4°C and 14,000 rpm for 20min. 
The pellets were resuspended in 1X Laemmli buffer with Tris and heated at 99°C for 3 
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min, and then were store at -80°C or separated on 8% SDS-PAGE gels. Proteins were 
transferred to a nitrocellulose membrane with Towbin buffer (25 mM Tris, 192 mM 
glycine, 20% methanol, 0.1% SDS, pH 8.3) or CAPS buffer (10 mM N-cyclohexyl-3-
aminopropanesulfonic acid, 10% methanol, pH 11) and subjected to Western blot analysis. 
2.6 Immunoprecipitation 
Fresh overnight cell cultures were diluted into 300 ml of ura- leu- galactose media 
to OD600 at 0.1. Glucose was added to the culture to final concentration at 2%, and 
continued growth for 6 h at 30°C. Cells were harvested and stored at -80°C. Cells were 
thawed on ice and whole cell extracts were prepared in IP buffer (50 mM Tris-HCl pH 7.5, 
100 mM NaCl, 1.5 mM MgCl2, 0.15% NP40, 1 mM PMSF, 1 μg/ml leupeptin, 1 μg/ml 
pepstatin A) by vortexing with glass beads, and clarifying by centrifugation at 14,000g at 
4°C.Extracts were normalized by OD280, Placental RNase inhibitor (New England Biolabs) 
was added to the samples and sample were incubated with Protein-G magnetic beads (New 
England Biolabs) pre-bound with anti-GFP antibody for 2 h at 4°C. The beads were washed 
with IP buffer three times for 5 min each at 4°C. Proteins and RNA were extracted from 
the beads with equal volume of LETS (10 mM Tris-HCl, pH7.4, 100 mM LiCl, 10 mM 
EDTA and 0.2% SDS) and acid-phenol: chloroform. The aqueous phase was re-extracted 
with acid-phenol: chloroform. The final aqueous phase was precipitated with 2.5 volumes 
100% ethanol and 1μl of 5 mg/ml glycogen (Ambion) overnight at -20°C. RNA was 
recovered by centrifugation, pellets washed with cold 70% ethanol, and northern blot 
analysis was performed. Proteins were recovered from the organic phase from the first 
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extraction by precipitation with acetone. Proteins were eluted in 1X Laemmli buffer and 
separated on 8% SDS-PAGE gels. Proteins were transferred to a nitrocellulose membrane 
with CAPS buffer and subjected to Western blot analysis. 
2.7 Western blot analysis 
Membranes were blocked with 5% milk in 1X TBS for 30 min at room temperature, 
and washed with 1X TBS 3 times for 5 min each. Membranes were then incubated with 
primary antibody diluted in 1X TBST with 1% milk for 2 h at room temperature. Primary 
antibodies used here were polyclonal rabbit anti-GFP antibody (1:5000, M. Rout), 
monoclonal mouse anti-c-myc antibody (9e10, 1:10,000, Biolegend), polyclonal rabbit 
anti-Mpp10 antibody (1:10,000, S. Baserga), polyclonal guinea pig anti-Imp4 antibody 
(1:3000, S. Baserga) and monoclonal mouse anti-HA antibody (1:5000).  Membranes 
were washed with 1X TBST 3 times for 5 min each, and then were incubated with 
secondary antibodies in 1X TBST with 1% milk for 30 min at room temperature. Secondary 
antibodies used here were polyclonal goat anti-mouse, goat anti-rabbit and goat anti-guinea 
pig HRP-coupled antibodies (1:30,000), anti-mouse and anti-rabbit fluorescent-coupled 
antibodies. Membranes were washed with 1X TBST 3 times for 5 min each. Finally, ECL 
solution (Thermo Scientific) was added on the surface of membranes which were then 
exposed to X-ray film. Membranes which contained the fluorescent signal were detected 
by Li-Cor Odessy. The images were analyzed with Li-Cor Image studio software.  
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2.8 Protein expression and purification 
Dhr1 and Dhr1D516A/E517A were expressed and purified as described before (21). 
His6-Utp14, His6-Utp14multi-Ala and His6-Utp14Δ719-850were expressed from pAJ3307, 
pAJ3315 and pAJ3314, respectively, overnight at 15°C in BL21 Star (DE3) (Life 
Technologies) cells supplemented with a vector expressing the tRNA genes argU, ileY and 
leuW. Cells were washed once and resuspended with extraction buffer (50 mM Tris-HCl 
pH 8.0, 500 mM NaCl, 10% [v/v] glycerol, 5 mM BME, 7 units/ml RNase A and 10 
units/ml RNase I). The extensive RNase treatment ensured the removal of tightly bound 
RNA. A French Press was used to lyse cells and cell extracts were clarified for 10 min at 
10,000g followed by 30 min at 50,000g. Supernatant was loaded on Ni-NTA resin 
(Invitrogen) and washed once with extraction buffer without RNase. The resin was then 
resuspended with 3 column volumes (CV) of extraction buffer and incubated 15 min. The 
resin was washed extensively with extraction buffer without RNase and protein was eluted 
with extraction buffer in which NaCl was replaced with 250 mM imidazole. Fractions 
containing Utp14 were pooled, supplemented with 1 mM DTT, and applied to CM Hitrap 
column (GE Healthcare Life Sciences). The column was washed with Buffer A (30 mM 
Tris pH 8.0, 5% [v/v] glycerol, 5 mM sodium acetate, and 1 mM DTT). Protein was eluted 
with a 21 CV gradient from 0% to 60% buffer B (buffer A plus 1 M NaCl). Utp14 
containing fractions were pooled, dialyzed (30 mM Tris pH 8.0, 10% [v/v] glycerol, 5 mM 
sodium acetate, 150 mM NaCl, and 1 mM DTT), and concentrated to ~5 μM. Aliquots 
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were flash frozen and stored at −80°C. Yield for WT and mutant Utp14 was approximately 
1 mg/liter. 
2.9 Preparation of Dhr1: Utp14 complex 
All reactions were performed at RT. To test the binding of Utp14 and Dhr1, 2 μM 
of Dhr1 with or without 2 μM Utp14 WT and mutants was first pre-incubated for 5 min, 
then bis[sulfosuccinimidyl] substrate (BS3) was added to a concentration of 2 mM. The 
reactions were incubated for 30 min then stopped by addition of 200 mM Tris [pH 8.0]. 
The reaction mix was analyzed by SDS-PAGE or mass-spec. 
2.10 Mass-Spectrometric Analysis 
Protein samples were subjected to analysis by surface enhanced laser desorption 
and ionization-time-of-flight (SELDI-TOF) mass spectrometry to examine the distribution 
of masses of protein components. Samples were spotted in three successive 2 µl aliquots 
onto individual spots of a ProteinChip H50 Array (BioRad) and allowed to partially air dry 
for one hour or overnight between applications. The chip was then washed three times with 
5 µl distilled water and with 5% MeOH respectively and air-dried prior to the addition of 
3 µl of 10 mg/ml sinapinic acid (BioRad) in 60% acetonitrile/0.1% formic acid. Controls 
omitting the air drying for multiple applications of the sample as well as omitting the formic 
acid with matrix crystallization indicated no difference in the distribution of multimers 
(data not shown). Samples were analyzed using a BioRadProteinChip System 4000 
Enterprise mass spectrometer calibrated against BioRad’s Protein Standards. The 
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acquisition mode was positive with source at 25 kV. The matrix attenuation was set up as 
500 Da. The sampling rate was 800 MHz. Each spot was divided into 10 partitions with 
210 shots/partition and the data were collected at a laser energy of 3300 nJ with a mass 
range between 10-200 kDa. 
2.11 RNA substrates 
U3 snoRNA was transcribed as previously described (36, 37) and purified by gel 
electrophoresis and refolded. ETS2 (5’-GGA UUU GGU GG-3’) was purchased from IDT. 
The 5’-end of ETS2 was phosphorylated with γ-[32P]-ATP (PerkinElmer, 150 μCi/μL) by 
T4 Polynucleotide Kinase (New England Biolabs). Radiolabeled ETS2 was purified by gel 
electrophoresis, precipitated by ethanol, resuspended in water, and stored at −20°C. 
Poly(A) was purchased from SIGMA. 
2.12 ATPase assay 
ATPase assays were performed as described before (21), except some reactions 
included 0.5 μM Utp14 and final reaction conditions were 1 mM ATP, 1 mM MgCl2, 32 
mM Tris (pH 8), 60 mMNaCl, 4% glycerol, 2 mM sodium acetate and 2.4 mM DTT. 
2.13 Unwinding reactions  
All unwinding reactions were performed at room temperature. Pre-steady state 
reactions: to form the U3-ETS2 duplex, bottom strand U3 snoRNA was incubated for 20 
min at 45C, then refolded on ice for 10 min, and subsequently annealed with 32P-ETS2 at 
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room temperature for 10min. The reaction was further incubated 10 min with buffer 
supplemented with MgCl2 at room temperature. The pre-formed U3-ETS2 duplex was 
incubated with Dhr1 (WT or mutant) in the presence or absence of Utp14 (WT or mutant) 
for 5 min and reactions were initiated by rapid addition of 1 mM mixture of ATP and 
MgCl2. The final concentrations were 1 mM ATP, 1.5 mM MgCl2, 1.5 nM bottom strand 
RNA, ≤0.3 nM 32P ETS2, 50 nM Dhr1, in the presence or absence of 200 nM Utp14, 20-
35 mM Tris (pH 8.0), 50 mM NaCl, 7% (v/v) glycerol, 2.7 mM DTT, 0.8 units/μl RNasin, 
and 0.2 mg/ml BSA. Reactions were sampled and quenched by addition of one-half volume 
of stop buffer (150 mM Tris [pH 8.0], 0.3% [w/v] SDS, and 150 mM EDTA). The amount 
of duplex and single stranded RNA for both of the above helicase reactions were resolved 












Charter 3 Results3 
3.1 Utp14 and Dhr1 Interact by yeast 2-hybrid analysis 
In our previous work, we identified multiple Dhr1 mutants and a single Utp14 
mutant that suppressed the growth defect of bud23Δmutant yeast. Based on the functional 
interactions of these proteins, I wanted to examine the potential physical interaction 
between Dhr1 and Utp14. I performed yeast two-hybrid studies and detected a robust 
interaction between these proteins (Figure 3.1). Next, I wanted to find out which region of 
Dhr1 is needed for this interaction. I first made a series of truncations. Dhr1can be divided 
into functional domains based on sequence homology and by extension of structural 
homology to Prp43 (38, 39) (Figure 3.1), which we used to construct a model (Figure.3.2). 
In our previous study, we found that the N-terminal domain (amino acids [aa] 1 to 356) 
contains a binding site for Bud23 (28). This domain is followed by the helicase core (aa 
375 to 839) composed of tandem RecA-like domains, designated RecA1 and RecA2. The 
core is followed by a winged helix domain (aa 840 to 905), a ratchet domain (aa 906 to 
1056), an OB fold (aa 1057 to 1192) and a small C-terminal extension (aa 1193 to 1267). 
Deletion of the N-terminal domain of Dhr1 had no effect on its interaction with Utp14 
(Figure 3.1). However, deletion of an additional 148 aas, extending into the RecA1 domain, 
or larger deletions, completely eliminated the two-hybrid interaction (Figure3.1). 
                                                 
3Chapter 3 is mainly based on previously published article: Zhu J, Liu X, Anjos M, Correll CC, Johnson 
AW. Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome. 
Mol Cell Biol. 2016;36(6):965-78. PMCID: 4810474. I contributed to 3.1, 3.3,, 3.5, 3.6, 3.9. 
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Likewise, deletion of the winged helix domain through the C-terminus completely 
eliminated two-hybrid interaction. I also checked the protein expression level by Western 
blotting and confirmed that all truncations were expressed as well as the wild-type protein 
(Figure 3.3). 
 
Figure 3.1 Mapping the Dhr1-Utp14 interaction and mapping the Dhr1 binding site on 
Utp14 by yeast two-hybrid. 
Cartoon of domain organization of Dhr1. Strain PJ69-4α was transformed with Gal4AD-
Utp14 and a second plasmid encoding Gal4BD fusions of either full-length Dhr1, or 
truncated proteins containing aa1-813, aa319-838 and aa319-1267. The truncated Dhr1 
mutant proteins, aa1-467, aa1-142 and aa467-1267, were fused with Gal4AD and were co-
expressed with Gal4BD-Utp14 in PJ69-4α. The transformants were patched on SD lacking 
either leucine and tryptophan (L-W-), or lacking leucine, tryptophan and histidine (L-W-







Figure 3.2 Homology model of Dhr1. 
Amino acids 375 to 1189 of Dhr1 were modeled on the structure of Prp43 (pdb 3KX2) 
using Phyre2 (40). The structure of residues 1 to 374 and 1190 to 1267 is unknown. The 
model of Dhr1 contains two RecA-like domains (RecA1 and RecA2), a feature shared by 
DEAD-box and viral DExH helicases. The two RecA-like domains are involved in ATP 
binding and hydrolysis and duplex binding. RecA2 also contains a β-hairpin. Downstream 
of the RecA-like domains there is winged-helix domain (WHD) followed by a rachet 
domain, similar to the processive DNA helicase Ski2-like Hel308. The C-terminal region 





Figure 3.3. Expression level of Dhr1 two-hybrid proteins. 
The protein level of Dhr1 truncated mutants. Gal4BD or Gal4AD fusions of either full-
length DHR1 or truncated mutants were transformed in PJ69-4α. Cells were lysed with 
NaOH (41). The extract was separated with 8% SDS-PAGE, and subjected to western 
blotting using anti-myc or anti-HA antibodies.  
 
This result was demonstrating that loss of two-hybrid interaction was not because 
of poor expression of the mutant proteins. Thus, all but the N-terminal domain of Dhr1 (aas 
1 to 318) is needed for two-hybrid interaction with Utp14. The winged helix, ratchet 
domain and OB fold are expected to create a base to orient the tandem RecA-like domains. 
Therefore, a relatively compact region of Utp14 could interact with disparate domains of 
Dhr1. I also tested these truncations of Dhr1 for their ability to complement loss of Dhr1 
(Figure 3.1 and Figure 3.4). Dhr1 lacking the N-terminus weakly complemented loss of 
Dhr1. Further deletions into the RecA-like domains or deletion of the remaining C-terminal 





Figure 3.4 Complementation of DHR1 truncated mutants. 
Empty vector, full-length DHR1 or truncated mutants were transformed into PGal1-DHR1 









In contrast to Dhr1, Utp14 has no structural homologs and thus no identifiable 
sequence motifs suggesting functions for Utp14. However, there are regions of strong 
conservation in the N-terminus (~aa 180 to 520) and in the C-terminus (~aa 750 to 895) 
(Figure 3.5). To narrow down the region of Utp14 that interacts with Dhr1, I made serial 
N- and C-terminal truncations (Figure 3.5). I tested these in two-hybrid assays with full 
length Dhr1 and titrated with 3 amino triazole (3AT) to better differentiate relative 
strengths of interaction (31). Utp141-813 and Utp141-706 (deleting 86 and 193 aas, 
respectively, from the C-terminus) showed increasingly severe reductions in two-hybrid 
interaction with Dhr1 and larger deletions showed no detectable interaction (Figure 3.5). 
Utp14266-899 (deletion of 265aas from the N-terminus) had no discernable effect on Dhr1 
interaction whereas Utp14565-899 and Utp14655-899 (deletion of 564 and 654aas, respectively, 
from the N-terminus) gave increasingly severe loss of interaction. These results show that 










Figure 3.5Mapping the Utp14 binding site on Dhr1by yeast two-hybrid. 
Cartoon of amino acid conservation of Utp14. Multiple sequence alignment was done with 
Geneious software. Black: 100% identity; dark gray: 80-100% similarity; light gray: 60-
80% similarity; white <60% similarity. Strain PJ69-4α was transformed with Gal4BD-
Dhr1 and a second plasmid encoding Gal4AD fusions of either full-length Utp14, or 
truncated Utp14. The transformants were patched on SD L-W-, SD L-W-H-, and SD L-W-





Figure 3.6. Complementation of UTP14 truncated mutants. 
Empty vector, full-length UTP14 or truncated mutants were transformed into PGal1-
UTP14 strain (AJY3243), grown on SD Ura- glucose medium and SD Ura- galactose for 






3.2 Mutations in UTP14 that suppress bud23∆ map to a highly conserved peptide in 
the C-terminus of Utp14 
A previous lab member, Joshua P. White, found that an alanine to glycine 
substitution at position 758 in Utp14 suppressed the growth and rRNA processing defects 
of bud23∆ (27). To better define the functional domain of Utp14 important for bud23∆ 
suppression, Margarida Anjos screened for additional suppressing mutations. She 
randomly mutagenized the entire open reading frame of UTP14 by PCR and recombined 
the mutant product into a UTP14 expression vector in bud23∆ cells. She assumed that 
additional suppressing mutations in UTP14 could be identified in the presence of genomic 
WT UTP14 because UTP14A758G is a dominant suppressor. Therefore, fast growing 
colonies were isolated and UTP14 was sequenced to identify suppressing mutations. In 
cases where multiple mutations were identified, she subcloned these to identify the specific 
mutation conferring suppression. She identified four additional unique mutations that 
suppressed bud23∆: V754G, I755T, E757G and A760P (Figure 3.7). All single point 
mutations suppressed bud23∆ to a similar extent (Figure 3.8A) and all fully complemented 
loss of Utp14 (Figure 3.8B). The clustering of mutations identified a short highly conserved 






Figure 3.7 Suppressing mutations map to a highly conserved motif in Utp14. 
Cartoon showing conservation of amino acid sequence across Utp14 (upper panel) as 
described in the legend to Figure 1. Multiple sequence alignment of the region of Utp14 
containing mutations that suppress bud23∆ (lower panel) was performed with T-coffee. S 
cerev, Saccharomyces cerevisiae; A thali, Arabidopsis thaliana; D melan, Drosophila 
melanogaster; X tropi, Xenopus tropicalis; D rerio, Danio rerio; G galus, Galus galus; H 
Sapiens, Homo sapiens. Positions of single amino acid substitutions that suppress bud23∆ 
are indicated by (▼). The amino acid changes of Utp14multi-Sup and Utp14multi-Ala are 
indicated. The consensus sequence of G-Patch proteins is shown below the alignment. 
Perfect matches with invariant residues are shaded in black and similar residues shaded in 
gray. 
 
3.3 Combining suppressing mutations or deletion of the region containing the 
mutations impairs Utp14 function 
Individually, the mutations in Utp14 fully complemented loss of Utp14 and 
therefore are expected to only slightly perturb a protein-protein or protein-RNA interaction 
to suppress bud23∆. To make more severely disruptive mutants I combined multiple 
suppressing mutations (Utp14multi-sup), changed multiple residues within this motif to 
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alanine (Utp14multi-Ala) or deleted this region entirely (Utp14∆719-780) which was done by 
Margarida Anjos. I tested whether these additional mutants had more severe phenotypes 
than the single point mutations. Indeed, these mutants displayed a gradation of function in 
the order: WT, Utp14multi-sup, Utp14multi-Ala, and Utp14∆719-780, which was lethal (Figure 
3.8B). None of the three mutants suppressed bud23∆ (Figure 3.8A). These more disruptive 
utp14 mutants allowed us to separate functions of Utp14 that could not be done with a 
complete loss of function mutant. 
 
Figure 3.8 Suppression and complementation assays of Utp14 suppressing mutants. 
(A) WT UTP14 or indicated mutants were expressed in a bud23∆ PGAL1-UTP14 strain 
AJY3245 and 10-fold serial dilutions of cells were spotted onto glucose-containing 
medium and grown for 2 days at 30°C. (B) WT UTP14 or indicated mutants were expressed 
in a PGAL1-UTP14 strain AJY3243 and 10-fold serial dilutions of cells were spotted onto 
glucose-containing medium and grown for 2 days at 30°C. 
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3.4 Impaired function of Utp14 correlates with loss of Dhr1 interaction 
Because the mutations that suppressed bud23∆ mapped within the region that we 
identified as important for interaction with Dhr1, Margarida Anjos tested if they affected 
interaction using yeast two-hybrid studies. Although the individual point mutants and 
combined Utp14multi-sup mutant had no obvious effect on Dhr1 interaction (Figure 3.9 and 
data not shown), Utp14multi-Ala and Utp14∆719-780 displayed increasing loss of interaction 
(Figure 3.9) that correlated with their reduced ability to complement loss of Utp14 (Figure 
3.8B). These results suggest that the motif identified by mutations that suppress bud23∆ 
contributes to interaction with Dhr1. 
 
Figure 3.9Utp14 mutants and Dhr1 interaction by yeast two-hybrid 
Combining suppressing mutations, multiple alanine substitutions or deletion of the region 
of Utp14 identified by suppressing mutations causes an increasing defect in Dhr1 




3.5 rRNA processing in utp14 mutants 
Cleavage at site A2 produces 20S and 27SA2 pre-rRNAs (Figure 3.10A) and is the 
primary event that separates the RNAs of the pre-40S subunit from the pre-60S subunit. 
We previously showed that deletion of BUD23, loss of UTP14, or a catalytically inactive 
dhr1 mutant results in loss of the 27SA2 pre-rRNA intermediate (21, 26, 27), indicating 
either a failure in A2 cleavage or a delay in A2 cleavage such that cleavage at A3 precedes 
cleavage at A2. I compared pre-rRNA processing in WT and utp14 mutant cells. As we 
have shown previously, WT cells displayed a strong signal for 27SA2 pre-rRNA, which 
was absent from Utp14-depleted cells (Figure 3.10B, lane 1). Utp14multi-Ala, Utp14multi-sup 
and Utp14∆719-708 cells contained decreasing amounts of 27SA2 RNA indicating an 
increasingly severe defect in cleavage at A2 (Figure 3.10B, lanes 3-5). The mutants also 
showed an increase in 35S and a modest increase in 23S RNA (Figure 3.10C, lanes 3-5), 
which results from cleavage at A3 without earlier cleavages at A0, A1 or A2. I also detected 
low levels of 21S, which increased with the severity of the growth defect of the mutant 
(Figure 3.10B, lanes 3-5). 21S results from correct processing at A0 and A1 to generate the 
mature 5’-end of 18S but is cleaved at A3 rather than A2 on the 3’-end. Despite the absence 
of cleavage at A2, 20S levels were not significantly altered. This is consistent with the 
notion that A2 cleavage occurs after A3 cleavage in these mutants. A similar phenotype of 
loss of 27A2 but not 20S pre-rRNA was seen for bud23∆ cells (26). These results suggest 
that the Utp14multi-Ala, Utp14multi-sup and Utp14∆719-708 mutants are hypomorphic alleles of 
UTP14 with defects intermediate between WT and complete loss of Utp14 function. The 
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loss of 27SA2 in these utp14 mutants was not due to loss of Utp14 protein, as these proteins 
were readily detected by western blotting (Figure 3.11). Rather, loss of 27SA2 must be due 
to a specific defect in the function of the mutant Utp14 proteins. 
 
Figure 3.10 Utp14 mutants show reduced 27SA2 pre-rRNA. 
(A) Cartoon for ribosomal RNA processing. (B and C) Northern blots:PGAL1-Utp14 
(AJY3243) containing empty vector (pAJ100) (lane 1), wild-type UTP14 (pAJ1919) (lane 
2), utp14multi-Sup(pAJ3264) (lane 3),  utp14multi-Ala(pAJ3276) (lane 4),and 
utp14∆719-780 (pAJ3276) (lane 5)  were grown in SD Ura- galactose medium and then 
shifted to SD Ura- glucose medium for 6 h at 30°C. All cultures were harvested at an 
OD600 of 0.3. Total RNA was extracted using hot-phenol, separated on a 1% agarose–
formaldehyde denaturing gel, transferred to a membrane, and probed with (B) probe 1 
(AJO603, site A2-A3) and (C) probe 2 (AJO130, site D-A2). U2 RNA (probed with 
AJO962) was used as a loading control. 
37 
 
3.6 Impaired function of Utp14 phenocopies a Dhr1 catalytic mutant 
I reasoned that Utp14 mutants with reduced interaction with Dhr1 should inhibit 
recruitment of Dhr1 to the pre-ribosome. To explore this idea I examined the sedimentation 
of Dhr1 in sucrose gradients in the presence of WT or mutant Utp14. WT and mutant Utp14 
were expressed in cells in which genomic Utp14 was under the control of the glucose-
repressible GAL1 promoter. In the presence of WT Utp14, Dhr1 sedimented primarily as 
free protein at the top of the gradient (Figure 3.11A, fractions 1, 2). However, in the 
presence of each of the three utp14 mutants, I observed a shift in the sedimentation of Dhr1 
from the top of the gradient to ~55S (Figure 3.11B-D, fractions 5, 6). The effect was greater 
for Utp14multi-Ala than for Utp14multi-sup, correlating with their severity of impact on function. 
Clearly, mutant Utp14 did not prevent recruitment of Dhr1 to the pre-ribosome. Rather, the 
data suggest that mutant Utp14 caused the accumulation of wild-type Dhr1 in the pre-
ribosome. Evidently, the function of Utp14 is more than merely binding to and recruiting 
Dhr1. The accumulation of Dhr1 was somewhat less pronounced for Utp14∆719-780 despite 
its more severe growth defect. We suspect this mutant is partially defective in recruitment 
of Dhr1 in addition to failing to activate Dhr1 (see below). 
We previously showed that mutant Dhr1K420A, which is defective for ATP binding 
and hydrolysis, arrests SSU maturation by trapping a U3 bound ~55S particle that also 
contains the U3 associated proteins Mpp10 and Imp4 (21). Therefore, I monitored the 
sedimentation of U3, Mpp10 and Imp4 in the presence of the Utp14 mutants. Indeed, these 
trans-acting factors also shifted in distribution with a significant fraction shifting from the 
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90S region (Figure 3.11A-D, fractions 9, 10) to cosediment with Dhr1 at ~55S (Figure 
3.11A-D, fraction 5-6). To confirm that the co-sedimentation of Dhr1 with mutant Utp14 
and U3 (Figure 3.11) reflected association with a pre-40S particle, Immunoprecipitated 
WT Utp14 or Utp14multi-Ala and probed for the presence of Dhr1, Imp4, Mpp10, U3 and 
pre-rRNAs. I observed an accumulation of Dhr1, Imp4 and Mpp10 in the Utp14multi-Ala 
sample compared to WT Utp14 (Figure 3.12A, compare lanes 3 and 4), demonstrating that 
these proteins accumulate in a common complex. I also observed a striking accumulation 
of 20S pre-rRNA as well as U3 in the Utp14multi-Alasample compared to WT (Figure 3.12B, 
compare lanes 3 and 4). However, I did not detect accumulation of 21S (Figure 3.12C). 
The lack of 27SA2 product (Figure 3.10 B, lane 4) and accumulation of 20S pre-rRNA in 
the Utp14 particle, could be explained if A2 cleavage is delayed relative to A3 cleavage in 
the Utp14multi-Ala mutant, so that 21S pre-rRNA is processed into 20S in the stalled particle, 
as we suggested for the catalytic dhr1 mutant dhr1K420A (21). Alternatively, a failure to 
recycle U3 from the stalled mutant Utp14 particle would also lead to reduction in U3-
dependent cleavages at A0, A1 and A2. The relative contributions to pre-rRNA processing 
of delayed cleavage at A2 and the consequences of failing to recycle U3 remain to be 
determined. I conclude that the altered sedimentation of Dhr1, U3, Imp4, Mpp10 and Utp14 
is due to accumulation of these factors on a stalled pre-40S particle. The similarity in 
phenotype between the utp14 mutants and the catalytic dhr1K420A mutant led us to posit that 





Figure3.11. Dhr1 sedimentation in utp14 mutants 
Whole-cell extracts were prepared from a PGAL1-UTP14 strain (AJY3243) containing 
plasmids expressing (A) wild-type UTP14 (pAJ3308), (B) utp14multi-Sup(pAJ3309), (C) 
utp14multi-Ala (pAJ3313), and (D) utp14∆719-780 (pAJ3310) grown in glucose medium 
for 6 h. Extracts were subjected to sucrose density gradient ultracentrifugation. Proteins 
were precipitated from fractions and subjected to western blotting and RNA was extracted 
and subjected to northern blotting. Utp14, Dhr1, Imp4 and Mpp10 were detected using 
anti-GFP (Utp14), anti-myc (Dhr1), anti-Imp4, and anti-Mpp10 antibodies, respectively. 







Figure 3.12 Utp14multi-Ala coimmunoprecipitates a pre-40S particle containing U3 and Dhr1. 
(A) Utp14 WT and the multi-alanine mutant were immunoprecipitated from extracts 
prepared from strains as described in Figure 3.11 Immunoprecipitated proteins were 
analyzed by SDS-PAGE and western blotting for Utp14, Dhr1, Imp4 and Mpp10. The 
asterisk indicates a probable proteolytic product of Imp4.(B, C) RNAs were extracted from 
the immunoprecipitated samples and analyzed by northern blotting with probe1 to detect 
pre-rRNAs containing the D-A2 fragment (B) and probe 2 to detect pre-rRNAs containing 





3.7 Utp14 stimulates the unwinding activity but not the ATPase activity of Dhr1. 
To assess whether Utp14 binds to and stimulates unwinding activity of Dhr1, Xin 
Liu, our collaborator, expressed and purified both proteins. Dhr1 was expressed with a C-
terminal His6 tag in Escherichia coli and the recombinant protein was purified as described 
(21). Utp14, Utp14multi-Ala and Utp14∆719-780were expressed with a N-terminal His6 tag in 
E. coli and purified (Materials and Methods).  I tested that Dhr1-His6 fully complemented 
a dhr1 null mutant (21) and His6-Utp14 fully complemented the utp14 null mutant in yeast 
(Figure 3.13). This result demonstrated that the tags did not interfere with the function of 
either protein in vivo. 
 
Figure 3.13 6xHis-UTP14 complements the function of UTP14. 
Empty vector (pRS416), untagged UTP14 (pAJ1919) and 6xHis-UTP14 (pAJ3331) were 
transformed in PGal1-UTP14 strain (AJY3243) and grown on SD Ura- glucose medium 
and SD Ura- galactose for 3 days at 30°C. 
 
To test if Utp14 stimulates unwinding activity of Dhr1, Xiu Liu used established 
assays with a substrate that mimics one of the three genetically verified U3-pre-rRNA 
duplexes: the U3-ETS2 duplex (21). The U3-ETS2 duplex comprises full-length U3 
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snoRNA bound to nts 281 to 291 of the 5’ETS of the pre-rRNA (Figure 3.14A) and is 
required for subsequent U3-pre-rRNA interactions in vivo(20). This duplex forms 
spontaneously and is stable in vitro (41). The U3-ETS2 duplex unwinding reactions were 
performed under pre-steady state conditions with an excess of enzyme over the duplex 
substrate and low substrate concentrations to minimize duplex re-formation. To enhance 
detection of Utp14-dependent stimulation of Dhr1 unwinding activity, the enzyme 
concentration was lowered to the point where unwinding activity by Dhr1 alone was barely 
detectable (Figure 3.14B, lane 4). Addition of Utp14 to a reaction containing Dhr1 resulted 
in a noteworthy increase in unwinding activity that was dependent onATP•Mg2+ (Figure 
3.14B, compare lanes 4, 5 and 6). No activity was observed with Utp14 alone in the 
presence of ATP•Mg2+ (Figure 3.14B, lane 8), indicating that this protein has no intrinsic 
helicase activity. Stimulation of Dhr1-dependent unwinding by Utp14 was also seen when 
both proteins were 500 nM, although the fold stimulation was reduced (data not shown). 
Compared with Utp14, Utp14multi-Ala and the Utp14Δ719-780 showed reduced activity (Figure 
3.14B, compare lane 6 with lanes 9 and 10). To quantitate these activities, he performed 
time course assays and fit the data to determine the unwinding (kunw) rate constant as 
described in (42). Addition of WT Utp14 to the Dhr1 reactions stimulated kunw by 98-fold, 
whereas the mutants showed less stimulation. Addition of Utp14multi-Ala and of Utp14Δ719-
780 to the Dhr1 reactions stimulated the kunw by 41-fold and 18-fold, respectively, in accord 




Figure 3.14 Utp14 activates Dhr1 unwinding activity in vitro. 
(A) Cartoon of U3-ETS2 substrate used for unwinding assays. Full length U3 snoRNA was 
used for the reactions in (B and C). (B) Representative unwinding reactions stopped after 
20 min. EMSAs separated the 32P-labeled ETS2 free (unwound) from its duplex form. The 
RT reaction contained 50 nM Dhr1 (WT or mutant), 200 nM Utp14 (WT or mutant), 1 mM 
ATP, ≤0.3 nM U3-ETS2 duplex with other reagents described in Materials and Methods. 
(C)Fraction unwound was plotted as a function of time after addition of:ATP and either 
Utp14 (black diamonds); Dhr1 (purple squares); Dhr1 in the presence of either Utp14 (red 
squares), Utp14Multi-Ala (green triangles), Utp14Δ719-780 (blue reverse triangles); or 
Dhr1 and Utp14 in the absence of ATP (red circles). (D) Fraction unwound was plotted as 
a function of time after addition of ATP and Dhr1D516A/E517A in the absence (purple 




Previously, we established that Dhr1 shares mechanistic similarities with DEAD 
box helicases in that unwinding requires ATP binding but not hydrolysis whereas product 
recycling requires ATP hydrolysis (21). To explore whether Utp14 stimulates Dhr1-
dependent unwinding, we tested the activity of the Dhr1D516A/E517A mutant, which 
eliminates the catalytic and metal binding carboxylates and thus probes the unwinding and 
not the recycling step (21). Utp14 stimulated the kunw of Dhr1D516A/E517A by 26-fold (Figure 
3.14D), which is less than 96-fold stimulation observed for WT Dhr1 (Figure 3.14C). Thus, 
Utp14 accelerates the Dhr1-dependent unwinding step; however, because Utp14 stimulated 
WT Dhr1 to a greater extent than Dhr1D516A/E517A, Utp14 must also contribute to other steps, 
such as substrate recruitment and/or product recycling. 
DEAH helicases are often activated by G-patch proteins that stimulate both 
unwinding and ATPase activity. To examine whether Utp14 shares these properties, we 
first analyzed sequence conservation within the Utp14 family. G-patch proteins are defined 
by a consensus sequence: hhx(3)Gax(2)GxGhGx(4)G where 𝑎 is an aromatic residue, h is 
hydrophobic, and 𝑥 can be any amino acid (24). Whereas many positions allow some 
divergence from this sequence the first glycine followed by an aromatic residue are 
invariant. Utp14 proteins contain a highly glycine-rich conserved motif, hPGWGxWxGxG. 
Even though the dipeptide GW is invariant, the larger motif does not fit the consensus of a 
G-patch protein. Dhr1 has RNA-stimulated ATPase activity (21). Consequently, Xin Liu 
tested whether Utp14 could stimulate the ATPase activity of Dhr1 like other G-patch 
proteins that activate the ATPase activities of helicases. The ATPase activity of Dhr1 was 
45 
 
indistinguishable in the presence or absence of Utp14, regardless of the presence or absence 
of poly(A) (Figure 3.15). Furthermore, Utp14 alone showed no intrinsic ATPase activity 
in contrast to its annotation as an ATPase (43). These results indicate that Utp14 stimulates 
Dhr1 unwinding activity without increasing its RNA-dependent ATPase activity. Thus, we 




Figure 3.15 Utp14 does not stimulate the ATPase activity of Dhr1. 
Initial velocities of Pi released after addition of 1 mM ATP at room temperature in the 
presence or absence of the poly(A)added to either Dhr1, Dhr1 with Utp14, Utp14, or mock 
with other reagents described in Materials and Methods. Each protein had a final 
concentration of 0.5 μM. In the activity units of min-1protein-1, protein refers to either Dhr1, 
Utp14 or the complex of the two. Similar results were obtained at 50 nM Dhr1 in the 




3.8 Dhr1 and Utp14 form a complex in vitro 
To determine the stoichiometry of the Dhr1:Utp14 complex, Xiu Liu performed 
crosslinking assays with BS3, a reagent that reacts with surface lysine residues, and used 
mass spectrometry to probe its stoichiometry (Materials and Methods). Crosslinking 
slightly altered migration of the individual proteins on SDS-PAGE (Figure 3.16A, compare 
lanes 8 to 11 with lanes 1 and 4). When both proteins were present, a slower migrating 
band was observed, correlating with loss of the individual protein bands (Figure 3.16A, 
compare lanes 5-7 with lanes 1-4), consistent with a Dhr1:Utp14 complex. Interestingly, 
neither Utp14multi-Ala  nor Utp14Δ719-780 produced as much of the higher order crosslinked 
species with Dhr1 as was observed with WT Utp14 and Dhr1 (Figure 3.16A, compare lane 
5 with lanes 6 and 7). Mass spectrometry verified that individual proteins modified by BS3 
showed increased mass: 166 kDa for Dhr1 and 122 kDa for Utp14. A heavier species was 
observed at 287 kDa only in the presence of both proteins, which was consistent with a 1:1 
stoichiometry of Dhr1:Utp14 (Figure 3.16B, compare red trace with black and blue traces). 
The low intensity of this 287 kDa species likely arose from the inefficiency of ionizing 
such a large complex. Together these results provide evidence that Dhr1 and Upt14 form a 
1:1 complex and that both Utp14 mutants weaken this interaction in accord with the two-
hybrid data (Figure 3.9). Whereas a 1:1 complex is observed, technical limitation of 





Figure 3.16 Dhr1 and Utp14 form 1:1 complex in vitro. 
(A) Representative cross-linking reactions stopped after 30 min. SDS-PAGE separated 
the cross-linked protein complex from individual protein. The RT reaction contained 2 μM 
of each protein with other reagents described in Materials and Methods. (B) Mass 
spectrometry analysis of the same sample of lane 1 (Utp14, black trace), lane 4 (Dhr1, blue 
trace) and lane 5 (both proteins, red trace) in panel A. Mass of the individual proteins, Dhr1 
(166 kDa) and Utp14 (122 kDa), have increased by more than 10% due to modification of 
the large number of lysine resides in each protein: 123 and 99, respectively. Upon addition 
of both proteins (red trace) a new mass appears, 287 kDa, consistent with formation of a 
1:1 complex. The upper right inset shows an enlargement of the intensity of the masses 
centered around 300 kDa. 
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3.9 Utp14and Bud23 together are required for efficient association of Dhr1 with the 
pre-ribosome 
A major question is how is Dhr1 recruited to and activated at the appropriate time 
during SSU biogenesis. To address this question I investigated whether Utp14 recruits 
Dhr1 to the pre-ribosome. Because WT Dhr1 does not stably associate with pre-ribosomes, 
I used the Dhr1K420A mutant that does stably interact with a ~55S pre-ribosomal particle 
((21) and Figure 3.17A, fraction 6). We previously showed that Bud23 binds to the N-
terminal domain of Dhr1 and that mutations in Dhr1 partially suppress the growth defect 
of bud23∆ cells (28). Despite the physical and functional interaction between Bud23 and 
Dhr1, loss of Bud23 has no observed effect on the sedimentation of Dhr1K420A ((28) and 
Fig. 8B). This suggests that Bud23 alone is not necessary for recruitment of Dhr1 to the 
pre-ribosome, contrary to a recent report (25). Given that Utp14 also interacts with Dhr1, 
I asked if Utp14 was required for association of Dhr1 with the pre-ribosome. Again, I did 
not observe any obvious change in the sedimentation of Dhr1K420A in the absence of Utp14 
(Figure 3.17C). However, when we eliminated both Utp14 and Bud23 by depleting Utp14 
from Bud23-deficient cells, we saw a significant loss of Dhr1K420Afrom the ~55S region of 
the gradient (Figure 3.17D, fractions 5, 6) and corresponding accumulation of free protein 
at the top of the gradient (Figure 3.17D, fractions 1, 2). These findings suggest that efficient 





Figure 3.17 Utp14 and Bud23 together are necessary for efficient Dhr1 recruitment to the 
pre-ribosome. 
Plasmid pAJ3081(dhr1K420A-13myc) was transformed into (A) Wild Type (BY4741), 
(B) bud23∆(AJY2161), (C)PGAL1-Utp14(AJY3243), and (D) PGAL1-Utp14 bud23∆ 
(AJY3245) strains.  Whole-cell extracts from strains grown in Leu- galactose that were 
shifted to Leu- glucose medium for 6 h, were subjected to sucrose density gradient 
ultracentrifugation. Proteins were precipitated from fractions and subjected to western 







Chapter 4 Discussion and Future Direction4 
My results identify Utp14 as an essential factor required for activating the 
DEAH/RHA helicase Dhr1, which removes U3 from the pre-ribosome to allow folding the 
CPK. In addition to activating Dhr1, Utp14 is also required for recruiting Dhr1 to the pre-
ribosome. I conclude this based on the result that both Utp14 and the RNA 
methyltransferase Bud23 are required for stable association of Dhr1 with the pre-ribosome. 
Thus, Utp14 has two functions: together with Bud23 it recruits Dhr1 to the pre-ribosome 
and it activates Dhr1 in the context of the pre-ribosome.  
I uncovered the connection between Utp14 and Dhr1 because mutations in either 
protein suppress the growth and ribosome biogenesis defects of a bud23∆ mutant (27, 28). 
In earlier work we showed that the utp14-A758G mutation partially suppressed the growth 
defect of bud23∆. Here, we found that additional mutations that suppress bud23∆ map to 
a short segment of Utp14 necessary for stimulation of Dhr1 unwinding activity and my 
results suggest that this is through direct physical interaction with Dhr1.  
BUD23, DHR1 and UTP14 are each needed for efficient cleavage at A2. 
Interestingly, whereas the single point mutation utp14-A758G suppresses the A2 cleavage 
defect of bud23∆ cells, simultaneous mutation of multiple residues in Utp14 eliminated 
suppression and resulted in an A2 cleavage defect. Apparently, subtle perturbation of the 
                                                 
4Chapter 4 is mainly based on previously published article: Zhu J, Liu X, Anjos M, Correll CC, Johnson 
AW. Utp14 Recruits and Activates the RNA Helicase Dhr1 To Undock U3 snoRNA from the Preribosome. 
Mol Cell Biol. 2016;36(6):965-78. PMCID: 4810474. I contributed to the whole chapter 4. 
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function of this peptide suppresses bud23∆ whereas more severe perturbation leads to loss 
of function. What then is the function of Bud23 and how do mutations in Utp14 suppress 
bud23∆? Since mutations in Utp14 reduce the activity of Dhr1 and suppress bud23∆, one 
possibility is that Bud23 slows or limits the activity of Dhr1. Bud23 and Utp14 are both 
needed for stable association of Dhr1 with the pre-ribosome. Perhaps in the absence of 
Bud23, ATP hydrolysis by Dhr1 leads to unproductive events and premature release of 
Dhr1. Thus, mutations that slow its activity could allow more time for productive 
engagement with its substrate. This thinking is analogous to what has been proposed for 
Prp5, a DEAD box helicase required for spliceosome assembly. Mutations in Prp5 that 
reduce its intrinsic ATPase activity increased the fidelity of splicing a suboptimal intron 
(44). Alternatively, Bud23 may stabilize an RNA structure in the pre-ribosome, consistent 
with the fact that Bud23 protein, but not its methyltransferase activity, is important for 
supporting ribosome assembly (26). Dhr1 action on a destabilized pre-40S may lead to 
mis-folding or mis-assembly that is recognized by surveillance systems, triggering discard 
of the subunit. Reducing the rate of Dhr1 unwinding could allow sufficient time for 
productive RNA-RNA or RNA-protein rearrangements in the absence of Bud23. 
The results presented in this work provide a compelling evidence for Utp14 
regulation of Dhr1 helicase function in small subunit biogenesis. However, there are still 
some key unanswered questions that need to be addressed. 
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4. 1 How is Utp14 recruited to the pre-ribosome at the appropriate time in SSU 
biogenesis? 
Utp14 was initially characterized as a component of the SSU Processome(9) and 
likely associates with the pre-ribosome before Bud23(27). Bud23 methylates G1575 in the 
3’-major head domain of the subunit (25, 26) and presumably binds to its RNA target site 
only after it is properly folded but before A2 cleavage, as bud23∆ mutants are defective for 
cleavage at this site (26). Both Utp14 and Bud23 remain associated with the subunit after 
A2 cleavage (27) and thus mark the transition from the 90S particle to the pre-40S particle. 
As most RNA helicases typically lack substrate specificity and need auxiliary factors for 
substrate recognition, and both Bud23 and Utp14 are needed for stable association of Dhr1 
with the pre-ribosome, I suggest that these two proteins, together, couple Dhr1 activity to 
the status of rRNA transcription and folding within the pre-ribosome. Thus, Utp14 must 
bind to the pre-ribosome earlier than or with Dhr1.  
It has recently been reported that Utp14 binds to the pre-ribosome only after 
completion of transcription of the 3’ minor domain of 18S rRNA (45). It is possible that 
Utp14 binding to the 3’-minor domain would provide a mechanism to ensure that Dhr1 is 
activated to remove U3 only after the entire 18S rRNA is transcribed. 
Since I found Utp14 is an RNA binding protein (unpublished data), a question is 
raised: is Utp14 recruited directly to a particular RNA sequence that needs only to be 
transcribed, or to an RNA structure that would require folding and possibly proteins to 
promote folding? In order to address this question, the Utp14 binding sites of pre-rRNA 
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could be identified by the UV cross-linking and analysis of cDNA (CRAC) method. The 
CRAC data will be confirmed by yeast three-hybrid assay and by testing if Utp14 loses 
interaction with pre-rRNA when mutating the specific nucleotides of pre-RNA.  
4.2 How does Utp14 activate Dhr1 to release U3 at the appropriate time in ribosome 
assembly? 
Base-pairing between U3 and the pre-rRNA orchestrates early RNA folding and 
cleavage events. However, these early events, leading to the cleavage at A2, occur very 
rapidly; in actively growing yeast, cleavage at A2 occurs within 50s of initiation of 
transcription (46). Thus, the binding and release of U3 is highly dynamic and must be 
driven by factors, such as Imp3, which promotes its annealing with pre-rRNA (41) and 
Dhr1, which promotes its dissociation (21). Whereas cleavage at A0, A1 and A2 are all 
U3-dependent, these three cleavage sites appear to separate into two functionally distinct 
groups. Production of the mature 5’ end of 18S by A0 and A1 cleavage requires U3 
docking, whereas efficient A2 cleavage is expected to require undocking of U3. Thus U3 
docking produces the 5’ end of 18S whereas U3 release signals SSU biogenesis by 
liberating the SSU 20S precursor from the pre-rRNA. In this model U3 docking and 
undocking provide distinct structural switches to mark steps during SSU biogenesis. 
Various DEAH/RHA RNA helicases depend on G-patch proteins for their 
recognition of substrates and for their activation (24). Here, we have shown that Utp14 
binds to and activates Dhr1 but neither possesses the canonical G-patch sequence nor 
stimulates ATPase activity upon activation of unwinding activity, two hallmarks of known 
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G-patch proteins that activate RNA helicases. In contrast, we found that Utp14 stimulated 
the helicase activity of Dhr1 without stimulating its ATPase activity. Such stimulation of 
unwinding without activation of ATPase activity is not without precedent. The Ski2-like 
RNA helicase Brr2 is required for pre-mRNA splicing and its unwinding activity can be 
stimulated by Prp8, which also reduces its ATPase activity (47). In this case, Prp8 increases 
the coupling between ATP hydrolysis and productive unwinding by Brr2 (48) by a 
mechanism that is unclear. Utp14 also appears to increase the coupling between ATP 
hydrolysis and productive unwinding by Dhr1, because the presence of Utp14 stimulates 
unwinding activity by Dhr1 without affecting rates of hydrolysis. 
A possible molecular basis of such stimulation is provided by the DNA helicase 
PcrAin which its activator RepD stimulates the unwinding PcrA without affecting ATPase 
activity (49, 50). RepD exploits a common feature of the reaction cycle of helicases with 
tandem RecA-like domains—these domains cycle between an open, inactive conformation 
and a closed, active conformation (51). In the active form the two RecA-like domains come 
together to form the NTP and RNA duplex binding cleft. Cross-linking and FRET studies 
suggest that RepD stimulates the helicase activity of PcrA by locking the tandem RecA-
like domains in an active closed conformation (39) and this is accomplished without 
stimulated ATPase activity (49). Perhaps Utp14 binding to Dhr1 similarly stabilizes a 




However, because Utp14 is an RNA binding protein, it is currently not easy to 
distinguish between roles in substrate recruitment and catalytic activation of Dhr1. This 
could be addressed if Utp14 could be separated into functional domains that separately 
bind RNA and activate Dhr1. In my unpublished data, I found that Utp141-265 but not 
Utp14707-899 binds to the pre-ribosome. As I have presented that Utp14multi-Ala and 
Utp14Δ719-780 have reduced activation of Dhr1 unwinding activity, it implies that the 
peptides for activating Dhr1 helicase function locate in Utp14707-899. These preliminary 
results suggest that Utp14 can be separated into pre-ribosome binding and Dhr1 activating 
domains. It will be of interest to express and purify these domains and test them in vitro 
assays for RNA binding and Dhr1 activation. The identification of a domain that lacks 
RNA binding but retains Dhr1 binding would allow us to separate the contributions of 





















1. Wilson DN, Doudna Cate JH. The structure and function of the eukaryotic 
ribosome. Cold Spring Harb Perspect Biol. 2012;4(5). PMCID: 3331703. 
2. Ramakrishnan V. Ribosome structure and the mechanism of translation. Cell. 
2002;108(4):557-72. 
3. Henras AK, Plisson-Chastang C, O'Donohue MF, Chakraborty A, Gleizes PE. An 
overview of pre-ribosomal RNA processing in eukaryotes. Wiley Interdiscip Rev RNA. 
2015;6(2):225-42. PMCID: 4361047. 
4. Mougey EB, O'Reilly M, Osheim Y, Miller OL, Jr., Beyer A, Sollner-Webb B. The 
terminal balls characteristic of eukaryotic rRNA transcription units in chromatin spreads 
are rRNA processing complexes. Genes Dev. 1993;7(8):1609-19. 
5. Bernstein KA, Gallagher JE, Mitchell BM, Granneman S, Baserga SJ. The small-
subunit processome is a ribosome assembly intermediate. Eukaryot Cell. 2004;3(6):1619-
26. PMCID: 539036. 
6. Henras AK, Soudet J, Gerus M, Lebaron S, Caizergues-Ferrer M, Mougin A, et al. 
The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell Mol Life Sci. 
2008;65(15):2334-59. 
7. Lamanna AC, Karbstein K. Nob1 binds the single-stranded cleavage site D at the 
3'-end of 18S rRNA with its PIN domain. Proc Natl Acad Sci U S A. 2009;106(34):14259-
64. PMCID: 2732849. 
8. Oeffinger M, Fatica A, Rout MP, Tollervey D. Yeast Rrp14p is required for 
ribosomal subunit synthesis and for correct positioning of the mitotic spindle during 
mitosis. Nucleic Acids Res. 2007;35(4):1354-66. PMCID: 1849896. 
9. Dragon F, Gallagher JE, Compagnone-Post PA, Mitchell BM, Porwancher KA, 
Wehner KA, et al. A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA 
biogenesis. Nature. 2002;417(6892):967-70. 
10. Krogan NJ, Peng WT, Cagney G, Robinson MD, Haw R, Zhong G, et al. High-
definition macromolecular composition of yeast RNA-processing complexes. Mol Cell. 
2004;13(2):225-39. 
11. Perez-Fernandez J, Roman A, De Las Rivas J, Bustelo XR, Dosil M. The 90S 
preribosome is a multimodular structure that is assembled through a hierarchical 
mechanism. Mol Cell Biol. 2007;27(15):5414-29. PMCID: 1952102. 
12. Beltrame M, Henry Y, Tollervey D. Mutational analysis of an essential binding site 
for the U3 snoRNA in the 5' external transcribed spacer of yeast pre-rRNA. Nucleic Acids 
Res. 1994;22(23):5139-47. PMCID: 523791. 
13. Hodnett JL, Busch H. Isolation and characterization of uridylic acid-rich 7 S 
ribonucleic acid of rat liver nuclei. J Biol Chem. 1968;243(24):6334-42. 
14. Hughes JM, Ares M, Jr. Depletion of U3 small nucleolar RNA inhibits cleavage in 
the 5' external transcribed spacer of yeast pre-ribosomal RNA and impairs formation of 
18S ribosomal RNA. EMBO J. 1991;10(13):4231-9. PMCID: 453175. 
57 
 
15. Beltrame M, Tollervey D. Identification and functional analysis of two U3 binding 
sites on yeast pre-ribosomal RNA. EMBO J. 1992;11(4):1531-42. PMCID: 556602. 
16. Hughes JM. Functional base-pairing interaction between highly conserved 
elements of U3 small nucleolar RNA and the small ribosomal subunit RNA. J Mol Biol. 
1996;259(4):645-54. 
17. Samarsky DA, Fournier MJ. Functional mapping of the U3 small nucleolar RNA 
from the yeast Saccharomyces cerevisiae. Mol Cell Biol. 1998;18(6):3431-44. PMCID: 
108924. 
18. Sharma K, Tollervey D. Base pairing between U3 small nucleolar RNA and the 5' 
end of 18S rRNA is required for pre-rRNA processing. Mol Cell Biol. 1999;19(9):6012-9. 
PMCID: 84488. 
19. Beltrame M, Tollervey D. Base pairing between U3 and the pre-ribosomal RNA is 
required for 18S rRNA synthesis. EMBO J. 1995;14(17):4350-6. PMCID: 394519. 
20. Dutca LM, Gallagher JE, Baserga SJ. The initial U3 snoRNA:pre-rRNA base 
pairing interaction required for pre-18S rRNA folding revealed by in vivo chemical 
probing. Nucleic Acids Res. 2011;39(12):5164-80. PMCID: 3130255. 
21. Sardana R, Liu X, Granneman S, Zhu J, Gill M, Papoulas O, et al. The DEAH-box 
helicase Dhr1 dissociates U3 from the pre-rRNA to promote formation of the central 
pseudoknot. PLoS Biol. 2015;13(2):e1002083. PMCID: 4340053. 
22. Colley A, Beggs JD, Tollervey D, Lafontaine DL. Dhr1p, a putative DEAH-box 
RNA helicase, is associated with the box C+D snoRNP U3. Mol Cell Biol. 
2000;20(19):7238-46. PMCID: 86278. 
23. Silverman E, Edwalds-Gilbert G, Lin RJ. DExD/H-box proteins and their partners: 
helping RNA helicases unwind. Gene. 2003;312:1-16. 
24. Robert-Paganin J, Rety S, Leulliot N. Regulation of DEAH/RHA helicases by G-
patch proteins. Biomed Res Int. 2015;2015:931857. PMCID: 4322301. 
25. Letoquart J, Huvelle E, Wacheul L, Bourgeois G, Zorbas C, Graille M, et al. 
Structural and functional studies of Bud23-Trm112 reveal 18S rRNA N7-G1575 
methylation occurs on late 40S precursor ribosomes. Proc Natl Acad Sci U S A. 
2014;111(51):E5518-26. PMCID: 4280632. 
26. White J, Li Z, Sardana R, Bujnicki JM, Marcotte EM, Johnson AW. Bud23 
methylates G1575 of 18S rRNA and is required for efficient nuclear export of pre-40S 
subunits. Mol Cell Biol. 2008;28(10):3151-61. 
27. Sardana R, White JP, Johnson AW. The rRNA methyltransferase Bud23 shows 
functional interaction with components of the SSU processome and RNase MRP. RNA. 
2013;19(6):828-40. PMCID: 3683916. 
28. Sardana R, Zhu J, Gill M, Johnson AW. Physical and functional interaction 
between the methyltransferase Bud23 and the essential DEAH-box RNA helicase Ecm16. 
Mol Cell Biol. 2014. 
29. Sondalle SB, Baserga SJ. Human diseases of the SSU processome. Biochim 
Biophys Acta. 2014;1842(6):758-64. PMCID: 4058823. 
58 
 
30. Phipps KR, Charette J, Baserga SJ. The small subunit processome in ribosome 
biogenesis-progress and prospects. Wiley Interdiscip Rev RNA. 2011;2(1):1-21. PMCID: 
3035417. 
31. James P, Halladay J, Craig EA. Genomic libraries and a host strain designed for 
highly efficient two-hybrid selection in yeast. Genetics. 1996;144(4):1425-36. PMCID: 
1207695. 
32. SenGupta DJ, Zhang B, Kraemer B, Pochart P, Fields S, Wickens M. A three-
hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci U S A. 
1996;93(16):8496-501. PMCID: 38700. 
33. Longtine MS, McKenzie A, 3rd, Demarini DJ, Shah NG, Wach A, Brachat A, et 
al. Additional modules for versatile and economical PCR-based gene deletion and 
modification in Saccharomyces cerevisiae. Yeast. 1998;14(10):953-61. 
34. Sardana R, Zhu J, Gill M, Johnson AW. Physical and functional interaction 
between the methyltransferase Bud23 and the essential DEAH-box RNA helicase Ecm16. 
Mol Cell Biol. 2014;34(12):2208-20. PMCID: 4054285. 
35. Li Z, Lee I, Moradi E, Hung NJ, Johnson AW, Marcotte EM. Rational extension of 
the ribosome biogenesis pathway using network-guided genetics. PLoS Biol. 
2009;7(10):e1000213. 
36. Gerczei T, Correll CC. Imp3p and Imp4p mediate formation of essential U3-
precursor rRNA (pre-rRNA) duplexes, possibly to recruit the small subunit processome to 
the pre-rRNA. Proc Natl Acad Sci U S A. 2004;101(43):15301-6. PMCID: 524450. 
37. Gerczei T, Shah BN, Manzo AJ, Walter NG, Correll CC. RNA chaperones 
stimulate formation and yield of the U3 snoRNA-Pre-rRNA duplexes needed for 
eukaryotic ribosome biogenesis. J Mol Biol. 2009;390(5):991-1006. PMCID: 2881153. 
38. He Y, Andersen GR, Nielsen KH. Structural basis for the function of DEAH 
helicases. EMBO Rep. 2010;11(3):180-6. PMCID: 2838688. 
39. Walbott H, Mouffok S, Capeyrou R, Lebaron S, Humbert O, van Tilbeurgh H, et 
al. Prp43p contains a processive helicase structural architecture with a specific regulatory 
domain. EMBO J. 2010;29(13):2194-204. PMCID: 2905241. 
40. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal 
for protein modeling, prediction and analysis. Nat Protoc. 2015;10(6):845-58. 
41. Shah BN, Liu X, Correll CC. Imp3 unfolds stem structures in pre-rRNA and U3 
snoRNA to form a duplex essential for small subunit processing. RNA. 2013;19(10):1372-
83. PMCID: 3854528. 
42. Yang Q, Jankowsky E. ATP- and ADP-dependent modulation of RNA unwinding 
and strand annealing activities by the DEAD-box protein DED1. Biochemistry. 
2005;44(41):13591-601. 
43. Woolford JL, Jr., Baserga SJ. Ribosome biogenesis in the yeast Saccharomyces 
cerevisiae. Genetics. 2013;195(3):643-81. PMCID: 3813855. 
44. Xu YZ, Query CC. Competition between the ATPase Prp5 and branch region-U2 
snRNA pairing modulates the fidelity of spliceosome assembly. Mol Cell. 2007;28(5):838-
49. PMCID: 2246091. 
59 
 
45. Chaker-Margot M, Hunziker M, Barandun J, Dill BD, Klinge S. Stage-specific 
assembly events of the 6-MDa small-subunit processome initiate eukaryotic ribosome 
biogenesis. Nat Struct Mol Biol. 2015;22(11):920-3. 
46. Kos M, Tollervey D. Yeast pre-rRNA processing and modification occur 
cotranscriptionally. Mol Cell. 2010;37(6):809-20. PMCID: 2860240. 
47. Maeder C, Kutach AK, Guthrie C. ATP-dependent unwinding of U4/U6 snRNAs 
by the Brr2 helicase requires the C terminus of Prp8. Nat Struct Mol Biol. 2009;16(1):42-
8. PMCID: 2707180. 
48. Mozaffari-Jovin S, Wandersleben T, Santos KF, Will CL, Luhrmann R, Wahl MC. 
Novel regulatory principles of the spliceosomal Brr2 RNA helicase and links to retinal 
disease in humans. RNA Biol. 2014;11(4):298-312. PMCID: 4075514. 
49. Toseland CP, Martinez-Senac MM, Slatter AF, Webb MR. The ATPase cycle of 
PcrA helicase and its coupling to translocation on DNA. J Mol Biol. 2009;392(4):1020-32. 
50. Arslan S, Khafizov R, Thomas CD, Chemla YR, Ha T. Protein structure. 
Engineering of a superhelicase through conformational control. Science. 
2015;348(6232):344-7. PMCID: 4417355. 
51. Ozgur S, Buchwald G, Falk S, Chakrabarti S, Prabu JR, Conti E. The 
conformational plasticity of eukaryotic RNA-dependent ATPases. FEBS J. 
2015;282(5):850-63. 
 
 
 
